ResMed launches AirSense 11 PAP series, advancing digital health in sleep apnea treatment. New digital features designed to make therapy setup and nightly use easier for patients.
Nihon Kohden announced the launch of POLYSMITH 12 polysomnography software, driven features that offer sleep specialists improved workflow, analysis and outcomes.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 183
Published Date: Feb 14, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing demand for home sleep apnea tests and advanced innovations in technology for devices are the major factors driving the growth of the sleep apnea devices market.
The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2033.
The high cost of devices and long waiting periods are the factors restraining the market growth.
The market in Asia Pacific is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The major players in the market are Philips Respironics, Curative Medical Inc., SOMNOmedics GmbH, Itamar Medical Ltd., Nihon Kohden Corporation, ResMed, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by disease type, by product type, by patient demographics, end user, distribution channel and by region.
The sleep apnea masks segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.